Search

Your search keyword '"Cocco E"' showing total 969 results

Search Constraints

Start Over You searched for: Author "Cocco E" Remove constraint Author: "Cocco E"
969 results on '"Cocco E"'

Search Results

1. Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives

2. An Overview of the Efficacy and Safety of Ozanimod for the Treatment of Relapsing Multiple Sclerosis

3. Home-based, computer-assisted cognitive rehabilitation for attention in pediatric onset multiple sclerosis: a randomized, multicenter pilot study

4. New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab

6. Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis

12. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

14. Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry

15. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

21. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis

22. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

24. Signs and symptoms of COVID-19 in patients with multiple sclerosis

28. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

29. Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis

31. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

32. The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis

33. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

34. Signs and symptoms of COVID-19 in patients with multiple sclerosis

35. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

40. Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

41. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

42. The Italian multiple sclerosis register

43. A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia

44. Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases

45. 1239P ORCHARD osimertinib + savolitinib interim analysis: A biomarker-directed phase II platform study in patients (pts) with advanced non-small cell lung cancer (NSCLC) whose disease has progressed on first-line (1L) osimertinib

47. Viability of a MSQOL-54 general health-related quality of life score using bifactor model

48. Geographic differences in the incidence of Huntington’s disease in Sardinia, Italy

49. MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study

Catalog

Books, media, physical & digital resources